Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Nothing changes
View:
Post by Bucknelly21 on Feb 28, 2022 11:16am

Nothing changes

Despite learning many valuable lessons from the market and some analysts thera continues on the same non effective path in regards to transparency and market engagement. Do we really think that even if they get good results from the 1a/b that they will be able to capture the appreciation that would be due? Idk even if a Chinese partnership is announced they have not shown me they are capable of doing a good deal. I hope im wrong but im just going off past experience
Comment by SPCEO1 on Feb 28, 2022 12:39pm
Given that the bubble has been popped, retain investors have been hammered and the bull market is gone too, the chances of a really good stock price response to any positive information TH might report in the weeks ahead is far less than it once was. Since TH still has no effective research coverage and has yet to hire a IR person (I am sure all noticed an LSA was the MC on the conference call ...more  
Comment by palinc2000 on Feb 28, 2022 1:15pm
Someone gave you a thumbs up for your post in which you mention that we may need a new CEO ?????? Gees!!!
Comment by SPCEO1 on Feb 28, 2022 2:19pm
Are you happy with the stock price since Paul took over?
Comment by palinc2000 on Feb 28, 2022 2:54pm
I posted not to long ago how Paul had been dealt a bad deal and I didn't not even mention the pandemic in that post What is very surprising is that not ONCE did you rant about Luc in you hundreds of posts..... And it now seems that a lot  of your posts are a about a rant against Paul....So in all logic you would trade Paul for Luc .....If that ever happens I would be out in 1 second ...more  
Comment by Bucknelly21 on Feb 28, 2022 3:25pm
Comment by jfm1330 on Feb 28, 2022 3:32pm
I still don't understand the thinking that lead you to think that a CEO can push the SP up without any meaninful achievement by the company he is leading. The last time Thera's SP went up significantly is after Trogarzo's approval. It was a mirage becauses sales never followed, but still, it was a significant achievement. If the CEO you want is a dream seller, say it clearly. Tanguay ...more  
Comment by palinc2000 on Feb 28, 2022 4:05pm
So Paul is getting flack because TH 1902 did not behave the same way in the dose escalation in  Phase 1 b in humans  as it did when administered to mice.....Shame on Paul!!!! 
Comment by Bucknelly21 on Feb 28, 2022 4:50pm
I think hes getting flack because hes missed every timeline hes set despite saying hes going to hold people accountable and hit those timelines
Comment by SPCEO1 on Feb 28, 2022 4:10pm
I absolutely want a CEO who sells a dream that is logical and can be achieved. I want him selling that as much as possible to investors as that is what investors respond to. And TH has just such a dream but TH has never been able to sell it effectively, even to a market that was crazy enough to buy into the lunatic dreams of CYDY among many, many others. Those crazy times have passed for now ...more  
Comment by jfm1330 on Feb 28, 2022 4:43pm
Please give us a break with Cytodyn. They are a fraudulent company. You talk about the rise pre Trogarzo approval. The problem is that now we are post Trogarzo approval, and it was another commercial failure and it is another stain on the company's resume. Add that to Egrifta's commercial failure. It is hard to sell dreams after that. I said it many times here and you don't want to ...more  
Comment by PinnacleX on Feb 28, 2022 6:36pm
 Funny how you ask him to drop his line of thinking, its you that should, and apologize to all your investors for being a naive, stubborn little man.  Same thing everyday from the same people here talking like they know better, but at the end of the day SP tells all.  
Comment by jeffm34 on Feb 28, 2022 6:42pm
I don't think there was much to be positive about in the near term from last weeks update. So what were the special share holders told in their private meetings last month that made them sound so positive ? 
Comment by qwerty22 on Feb 28, 2022 1:59pm
All we've really had so far is really updates to tell us where we are in the trial not what this drug is capable of (or not). We know 420 is too far and they 300 is a potentially dose moving forward. That's about it. And getting that info is adding 3 or so months to the process. It's still a fact they need to reach an end to this expansion phase before they can start putting the facts ...more  
Comment by Bucknelly21 on Feb 28, 2022 3:23pm
[what is paul actually responsible for that is so successful? Nash was not him, and neither was oncology, just wonding how you justify a fat salary wjile delivering nothing  quote=SPCEO1]Given that the bubble has been popped, retain investors have been hammered and the bull market is gone too, the chances of a really good stock price response to any positive information TH might report in ...more  
Comment by palinc2000 on Feb 28, 2022 3:30pm
I thought you had bailed out of THTX ...so why do you care? [/quote]
Comment by SPCEO1 on Feb 28, 2022 3:56pm
I have heard from someone at TH that I trust that Paul is very good at his job. He did not start the NASH process but he did make the transition to general NASH successful by bringing the FDA on board with that and this was a real long shot in my view. And he did not buy Katanna but he seems to have managed that process pretty well with the very large exception of the excessive amount of time ...more  
Comment by SPCEO1 on Feb 28, 2022 3:58pm
I should have also said that Paul has not done much for the sales of the legacy drugs but I don't really knock him for that as I think no one could have actually done any better than he did. [/quote]
Comment by Scioto1 on Mar 01, 2022 10:10am
Thanks for sharing your onsights, SPCEO. You are right. They work for us. How do we use the upcoming annual meeting to advance improvement of shareholder value as a Company priority?
Comment by Scioto1 on Mar 01, 2022 10:18am
My question is not just directed to SPCEO, it's directed to all of us, especially our most active brain trust. We all want the company to succeed and stock price to rise. How do we use the annual meeting to continue to advance "improving shareholder value" as a priority?
Comment by houbahop on Mar 01, 2022 3:13pm
The same question, again and again in the last 20 years... Deception and more deception, until the next round of share printing which will be accompanied with more promisses that will eventually result in more deception.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities